[Intra-arterial infusion chemotherapy for advanced endometrial cancer before surgical treatment]. 1998

I Ono, and C Kuwae, and M Kaneko, and T Ishibashi, and R Minaguchi, and T Kobayashi, and A Kohyama, and H Kitada, and H Ohtsuka
Dept. of Gynecology, Tokyo Metropolitan Fuchu Hospital.

Nine cases of advanced uterine body cancer (stage III: 8, stage IVa: 1) were treated by intra-arterial infusion chemotherapy before curative operation. This treatment produced primary tumors smaller than half sizes in eight cases. Necrotic changes were found in over two-thirds of the lesions in six cases. This chemotherapy enabled us to operate curatively in seven cases. After the operations, we performed various types of treatment including intra-arterial infusion chemotherapy. No evidences of disease have been found in four cases, but there is no significant difference between the groups receiving and not receiving the intra-arterial infusion chemotherapy (n = 16) in terms of survival rate of stage III. Further study of the prognosis is necessary.

UI MeSH Term Description Entries
D007044 Hysterectomy Excision of the uterus. Hysterectomies
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011300 Preoperative Care Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed) Care, Preoperative,Preoperative Procedure,Preoperative Procedures,Procedure, Preoperative,Procedures, Preoperative
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration

Related Publications

I Ono, and C Kuwae, and M Kaneko, and T Ishibashi, and R Minaguchi, and T Kobayashi, and A Kohyama, and H Kitada, and H Ohtsuka
August 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
I Ono, and C Kuwae, and M Kaneko, and T Ishibashi, and R Minaguchi, and T Kobayashi, and A Kohyama, and H Kitada, and H Ohtsuka
August 1992, Gan to kagaku ryoho. Cancer & chemotherapy,
I Ono, and C Kuwae, and M Kaneko, and T Ishibashi, and R Minaguchi, and T Kobayashi, and A Kohyama, and H Kitada, and H Ohtsuka
June 1991, Gan to kagaku ryoho. Cancer & chemotherapy,
I Ono, and C Kuwae, and M Kaneko, and T Ishibashi, and R Minaguchi, and T Kobayashi, and A Kohyama, and H Kitada, and H Ohtsuka
July 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
I Ono, and C Kuwae, and M Kaneko, and T Ishibashi, and R Minaguchi, and T Kobayashi, and A Kohyama, and H Kitada, and H Ohtsuka
November 1975, Cancer,
I Ono, and C Kuwae, and M Kaneko, and T Ishibashi, and R Minaguchi, and T Kobayashi, and A Kohyama, and H Kitada, and H Ohtsuka
January 1997, Acta oncologica (Stockholm, Sweden),
I Ono, and C Kuwae, and M Kaneko, and T Ishibashi, and R Minaguchi, and T Kobayashi, and A Kohyama, and H Kitada, and H Ohtsuka
October 2005, Gan to kagaku ryoho. Cancer & chemotherapy,
I Ono, and C Kuwae, and M Kaneko, and T Ishibashi, and R Minaguchi, and T Kobayashi, and A Kohyama, and H Kitada, and H Ohtsuka
September 1996, Gan to kagaku ryoho. Cancer & chemotherapy,
I Ono, and C Kuwae, and M Kaneko, and T Ishibashi, and R Minaguchi, and T Kobayashi, and A Kohyama, and H Kitada, and H Ohtsuka
February 2002, Gan to kagaku ryoho. Cancer & chemotherapy,
I Ono, and C Kuwae, and M Kaneko, and T Ishibashi, and R Minaguchi, and T Kobayashi, and A Kohyama, and H Kitada, and H Ohtsuka
June 2005, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!